Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/JSS stock hub

FRA/JSS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/JSSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

580.7M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/JSSFRA/JSS

—

Loading chart…

In the news

Latest news · FRA/JSS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-15.3

P25 n/aP50 n/aP75 n/a

ROIC-2.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/JSS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

JPY

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	382
Employees Change	12%
Employees Change Percent	3.23
Enterprise value	EUR 820.7M
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 580.7M
Price	EUR 6.2
Price currency	EUR
Rev Per Employee	488,724.38x
Sic	2836
Symbol	fra/JSS
Website	https://www.nxera.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.37%
EV Earnings	-15.08x
EV/EBITDA	101.06x
EV/FCF	-26.97x
EV/Sales	4.42x
FCF yield	-5.24%
P/B ratio	1.67x
P/S ratio	3.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.27%
EBITDA Margin	4.54%
Gross margin	77.5%
Gross Profit	EUR 144.7M
Gross Profit Growth	16.2%
Gross Profit Growth Q	101.59%
Gross Profit Growth3 Y	21.85%
Gross Profit Growth5 Y	26.85%
Net Income	EUR -54.4M
Pretax Margin	-28.49%
Profit Margin	-29.15%
Profit Per Employee	EUR -142,461
ROA	-1.27
Roa5y	-0.92
ROCE	-2.39
ROE	-15.26
Roe5y	-7.1
ROIC	-2.75
Roic5y	-0.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.77%
Cagr3y	-30.9%
Cagr5y	-13.36%
Revenue Growth	10.88x
Revenue Growth Q	69.42x
Revenue Growth3 Y	30.52x
Revenue Growth5 Y	30.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.25
Assets	EUR 727.3M
Cash	EUR 63.3M
Current Assets	EUR 210.2M
Current Liabilities	EUR 80.5M
Debt	EUR 304.5M
Debt EBITDA	EUR 35.93
Debt Equity	EUR 0.88
Debt FCF	EUR -10.01
Equity	EUR 347.4M
Interest Coverage	-3.21
Liabilities	EUR 379.9M
Long Term Assets	EUR 517.1M
Long Term Liabilities	EUR 299.5M
Net Cash	EUR -241.3M
Net Cash By Market Cap	EUR -41.55
Net Debt EBITDA	EUR 28.46
Net Debt Equity	EUR 0.69
Tangible Book Value	EUR -84.3M
Tangible Book Value Per Share	EUR -0.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.61
Inventory Turnover	0.77
Net Working Capital	EUR 104M
Quick ratio	1.73
Working Capital	EUR 130.8M
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.76%
200-day SMA	4.98
3Y total return	-67.02%
50-day SMA	5.06
50-day SMA vs 200-day SMA	50over200
5Y total return	-51.18%
All Time High	23.34
All Time High Change	-73.44%
All Time High Date	2019-08-13
All Time Low	4.04
All Time Low Change	53.47%
All Time Low Date	2025-12-19
ATR	0.16
Ch YTD	40.91
High	6.2
High52	6.2
High52 Date	2026-05-08
High52ch	0%
Low	6.2
Low52	4.04
Low52 Date	2025-12-22
Low52ch	53.47%
Ma50ch	22.48%
Price vs 200-day SMA	24.47%
RSI	73.69
RSI Monthly	48.3
RSI Weekly	65.11
Sharpe ratio	0.5x
Sortino ratio	0.91
Total Return	-0.65%
Tr YTD	40.91
Tr1m	15.89%
Tr1w	22.77%
Tr3m	41.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -15.4M
Operating margin	-8.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,873,531%
Net Borrowing	-80,734,037.3
Shares Insiders	11.79%
Shares Institutions	21.83%
Shares Qo Q	15.66%
Shares Yo Y	0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -28.3M
Average Volume	0x
Bv Per Share	3.84
CAPEX	EUR -3.5M
Ch1m	15.89
Ch1w	22.77
Ch1y	13.76
Ch3m	41.55
Ch3y	-67.02
Ch5y	-51.18
Ch6m	43.52
Change	5.08%
Change From Open	0
Close	5.9
Days Gap	5.08
Depreciation Amortization	23,734,161.5
Earnings Date	2026-05-01
EBIT	EUR -15.4M
EBITDA	EUR 8.5M
EPS	EUR -0.6
F Score	4
FCF	EUR -30.4M
FCF EV Yield	-3.71x
Financing CF	-87,419,993
Fiscal Year End	December
Founded	1,990
Goodwill	138,323,884.2
Income Tax	EUR 1.2M
Investing CF	-19,789,089
Is Primary Listing	0
Last Earnings Date	2026-05-01
Last Report Date	2026-03-31
Ma150	4.85
Ma150ch	27.84%
Ma20	5.3
Ma20ch	17%
Net CF	-124,734,535
Next Earnings Date	2026-08-07
Open	6.2
Ppne	39,241,202.1
Price Date	2026-05-08
Price EBITDA	EUR 68.51
Relative Volume	133.33x
Revenue	186,692,712x
SBC By Revenue	-1.13x
Share Based Comp	-2,116,363
Tax By Revenue	0.66x
Tr6m	43.52%
Volume	0
Z Score	0.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/JSS pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/JSS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/JSS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.8%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

FRA/JSS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.7

Above 70: short-term overbought

Price vs 200-day MA

+24.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/JSS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/JSS stock rating?

fra/JSS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/JSS analysis?

The full report lives at /stocks/fra/JSS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/JSS?

The latest report frames fra/JSS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/JSS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.